Clinical Trial Update: CMV Specific T Cell Therapy After Allogeneic Stem Cell Transplantation. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating CMV-specific T cell therapy after allogeneic stem cell transplantation in hematologic malignancies with CMV infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection
• Hematological Malignancies

Drugs mentioned

• CMV-specific T cell therapy (CMV-specific T cells)

Snippet

Sponsor: University Hospital, Ghent | Conditions: Hematological Malignancies, CMV Infection | Phase 2 | Status: COMPLETED